Insider · CIK 0002012448
John Spinale
Files at AKLI (Akili, Inc.). First filing -, latest -.
In brief
John Spinale files SEC Form 4 as director at AKLI (Akili, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Spinale has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | AKLI Akili, Inc. | UTender of shares Common Stock, par value $0.0001indirect: By JAZZ Human Performance Opportunity Fund, L.P. | -693,226 | - | - | 0 | Jul 2, 2024 |
| Jul 2, 2024 | AKLI Akili, Inc. | UTender of shares Common Stock, par value $0.0001indirect: By JAZZ Human Performance Technology Fund, L.P. | -3,063,364 | - | - | 0 | Jul 2, 2024 |
| Jul 2, 2024 | AKLI Akili, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -44,000 | - | - | 0 | Jul 2, 2024 |
| Feb 22, 2024 | AKLI Akili, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Feb 23, 2024 |
Questions about John Spinale
Answered from the filings on this page, as of the latest one.
Is John Spinale buying or selling?
John Spinale has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Spinale's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Spinale has 0.
Where does John Spinale file Form 4?
John Spinale has filed Form 4 at AKLI (Akili, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.